Immune-based therapy for spinal cord repair: autologous macrophages and beyond - PubMed (original) (raw)
Review
. 2006 Mar-Apr;23(3-4):360-70.
doi: 10.1089/neu.2006.23.360.
Affiliations
- PMID: 16629622
- DOI: 10.1089/neu.2006.23.360
Review
Immune-based therapy for spinal cord repair: autologous macrophages and beyond
Michal Schwartz et al. J Neurotrauma. 2006 Mar-Apr.
Abstract
Spinal cord injury is a devastating condition of the central nervous system (CNS), often resulting in severe loss of tissue, functional impairment, and only limited repair. Studies over the last few years have shown that response to the insult and spontaneous attempts at repair are multiphasic processes, with varying and sometimes conflicting requirements. This knowledge has led to novel strategies of therapeutic intervention. Our view is that a pivotal role in repair, maintenance, healing, and cell renewal in the CNS, as in other tissues, is played by the immune system. The mode and timing of intervention must be carefully selected, however, as the capacity of the CNS to tolerate local repair mechanisms is limited. Studies have shown that the spontaneously evoked early innate response to CNS injury is characterized by invasion of neutrophils and is unfavorable for cell survival. This is followed by a response of the resident innate immune cells (microglia), which however cannot supply all the needs of the damaged tissue; moreover, once evoked, and for as long as the damage persists, the microglial response remains beyond the capacity of the CNS to tolerate it. Immune-based clinical intervention is most effective in improving functional and morphological recovery when delayed for a certain period. Effective intervention might be in the form of (1) local injection of "alternatively activated" macrophages, (2) systemic injection of dendritic cells specific to CNS antigens, or (3) T-cell-based vaccination. The treatment of choice depends on the severity of the insult, the site of injury, the therapeutic window, and safety considerations.
Similar articles
- Boosting T-cell immunity as a therapeutic approach for neurodegenerative conditions: the role of innate immunity.
Schwartz M, London A, Shechter R. Schwartz M, et al. Neuroscience. 2009 Feb 6;158(3):1133-42. doi: 10.1016/j.neuroscience.2008.12.013. Epub 2008 Dec 14. Neuroscience. 2009. PMID: 19103265 Review. - Immunological approaches to the treatment of spinal cord injury.
Schwartz M. Schwartz M. BioDrugs. 2001;15(9):585-93. doi: 10.2165/00063030-200115090-00003. BioDrugs. 2001. PMID: 11580302 Review. - Microglia in central nervous system repair after injury.
Jin X, Yamashita T. Jin X, et al. J Biochem. 2016 May;159(5):491-6. doi: 10.1093/jb/mvw009. Epub 2016 Feb 8. J Biochem. 2016. PMID: 26861995 Review. - Activated macrophage/microglial cells can promote the regeneration of sensory axons into the injured spinal cord.
Prewitt CM, Niesman IR, Kane CJ, Houlé JD. Prewitt CM, et al. Exp Neurol. 1997 Dec;148(2):433-43. doi: 10.1006/exnr.1997.6694. Exp Neurol. 1997. PMID: 9417823
Cited by
- Unraveling the lymphatic system in the spinal cord meninges: a critical element in protecting the central nervous system.
Gonuguntla S, Herz J. Gonuguntla S, et al. Cell Mol Life Sci. 2023 Nov 20;80(12):366. doi: 10.1007/s00018-023-05013-1. Cell Mol Life Sci. 2023. PMID: 37985518 Free PMC article. Review. - Recent Advances in the Role of Nuclear Factor Erythroid-2-Related Factor 2 in Spinal Cord Injury: Regulatory Mechanisms and Therapeutic Options.
Jiang T, He Y. Jiang T, et al. Front Aging Neurosci. 2022 Jun 10;14:851257. doi: 10.3389/fnagi.2022.851257. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35754957 Free PMC article. Review. - MicroRNA-421-3p-abundant small extracellular vesicles derived from M2 bone marrow-derived macrophages attenuate apoptosis and promote motor function recovery via inhibition of mTOR in spinal cord injury.
Wang J, Rong Y, Ji C, Lv C, Jiang D, Ge X, Gong F, Tang P, Cai W, Liu W, Fan J. Wang J, et al. J Nanobiotechnology. 2020 May 13;18(1):72. doi: 10.1186/s12951-020-00630-5. J Nanobiotechnology. 2020. PMID: 32404105 Free PMC article. - Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury.
Gao J, Sun Z, Xiao Z, Du Q, Niu X, Wang G, Chang YW, Sun Y, Sun W, Lin A, Bresnahan JC, Maze M, Beattie MS, Pan JZ. Gao J, et al. Br J Anaesth. 2019 Dec;123(6):827-838. doi: 10.1016/j.bja.2019.08.026. Epub 2019 Oct 14. Br J Anaesth. 2019. PMID: 31623841 Free PMC article. - Macrophage Transplantation Fails to Improve Repair of Critical-Sized Calvarial Defects.
Borrelli MR, Hu MS, Hong WX, Oliver JD, Duscher D, Longaker MT, Lorenz HP. Borrelli MR, et al. J Craniofac Surg. 2019 Nov-Dec;30(8):2640-2645. doi: 10.1097/SCS.0000000000005797. J Craniofac Surg. 2019. PMID: 31609958 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical